Management Team

Walter Greenblatt

Chairman of the Board and Acting CEO; Managing Director, Walter Greenblatt & Associates: Walter founded WG&A in 1998 focused solely on early stage life science companies. Since 2002, the firm has raised $122M in seed and Series A round capital for early stage life science companies and returned, to date, $622M to investors in those rounds. An experienced entrepreneur and “hands-on” operating executive, Walter has founded and grown to profitability a series of successful operating businesses. Earlier in his career he worked as a strategic consultant at Bain & Company in a variety of industries in including healthcare. Walter holds an BS from Yale University, an MA from Oxford University and an MBA from Harvard Business School.

Kathleen Deardorff

Acting Chief Operating Officer: Kathleen has in depth cross functional proficiency, encompassing R&D, Commercial, Finance, Investor Relations. Manufacturing, Regulatory with expertise in Marketing in both large and small company settings in both diagnostic and therapeutic pharmaceutical portfolios; Previous roles: Chief Operating Officer, Photocure ASA, GE Healthcare Medical Diagnostics, Chief Marketing Officer, Bristol-Myers Squibb Co, Vice President Oncology Marketing, US; Senior Director, Worldwide Oncology Franchise Mgmt. Kathleen holds a Pharm D and a BS Pharmacy from Purdue University School of Pharmacy.